We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2267:TSEYakult Honsha Co., Ltd. Analysis

Data as of 2026-06-20 - not real-time

¥2,703.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Yakult’s share price is trading well above the DCF‑derived fair value, indicating a premium that may be hard to sustain. The 20‑day simple moving average sits just below the current price while the 50‑day average remains higher, suggesting a neutral to slightly bearish medium‑term bias. Momentum is mixed, with the RSI hovering around the midpoint and the MACD histogram turning positive, hinting at a modest bullish signal. The stock enjoys a solid dividend yield that exceeds the market average, and the payout ratio is comfortably below the typical threshold for sustainability. Support around the low‑2600 level appears intact, whereas resistance near the high‑2800 zone may cap upside in the near term. Trading volume has been stable, providing adequate liquidity for investors.
Fundamentally, revenue growth is modest and operating margins are thin, reflecting the low‑growth nature of the consumer defensive sector. Return on equity is modest and free cash flow is slightly negative, raising concerns about long‑term profitability. The company carries a high debt‑to‑equity ratio, though its cash holdings are substantial, resulting in a net cash position. The overall risk profile is tempered by low beta and defensive sector positioning, but the high 30‑day volatility adds a layer of price risk. Given the overvaluation, limited growth prospects, and mixed cash flow dynamics, the stock is best approached with caution. Investors may consider holding or reducing exposure while monitoring for any price correction toward fair value.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram
  • Support level intact
  • Attractive dividend yield

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Price above DCF fair value
  • Modest revenue growth
  • Stable liquidity

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Overvaluation relative to fundamentals
  • Negative free cash flow
  • Low ROE

Key Metrics & Analysis

Financial Health

Revenue Growth1.10%
Profit Margin9.09%
P/E Ratio17.9
ROE7.74%
ROA3.16%
Debt/Equity17.44
P/B Ratio1.3
Op. Cash Flow¥52.1B
Free Cash Flow¥-2489374976

Technical Analysis

TrendNeutral
RSI51.0
Support¥2,604.50
Resistance¥2,827.50
MA 20¥2,683.05
MA 50¥2,718.91
MA 200¥2,554.16
MACDBullish
VolumeStable
Fear & Greed Index91.46

Valuation

Fair Value¥2,151.26
Target Price¥2,500.00
Upside/Downside-7.51%
GradeOvervalued
TypeValue
Dividend Yield2.73%

Risk Assessment

Beta-0.17
Volatility45.35%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.